Legal & General Group PLC Tricida, Inc. Transaction History

Legal & General Group PLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$8.51 - $13.6 $12,033 - $19,230	-1,414 Reduced 12.73%	9,694 $101,000
Q2 2022 Aug 22, 2022	BUY	$7.31 - $11.85 $81,199 - $131,629	11,108 New	11,108 $107,000
Q2 2021 Aug 12, 2021	SELL	$3.95 - $5.41 $17,214 - $23,576	-4,358 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.52 - $7.8 $30,713 - $53,001	-6,795 Reduced 60.93%	4,358 $23,000
Q3 2020 Nov 13, 2020	SELL	$8.56 - $26.93 $10,443 - $32,854	-1,220 Reduced 9.86%	11,153 $101,000

Q2 2020 Aug 14, 2020	BUY	$21.21 - $31.55 $24,539 - $36,503	1,157 Added 10.32%	12,373 $340,000
Q1 2020 May 14, 2020	SELL	$18.43 - $38.04 $17,821 - $36,784	-967 Reduced 7.94%	11,216 $247,000
Q4 2019 Feb 13, 2020	SELL	$29.6 - $43.71 $4,558 - $6,731	-154 Reduced 1.25%	12,183 $460,000
Q3 2019 Nov 13, 2019	BUY	$29.87 - $42.22 $247,652 - $350,046	8,291 Added 204.92%	12,337 $380,000
Q2 2019 Aug 14, 2019	BUY	$31.16 - $39.46 $20,659 - $26,161	663 Added 19.6%	4,046 $160,000
Q1 2019 May 15, 2019	BUY	$19.96 - $38.62 $24,311 - $47,039	1,218 Added 56.26%	3,383 $131,000
Q4 2018 Feb 15, 2019	BUY	$23.57 - $32.33 $9,545 - $13,093	405 Added 23.01%	2,165 $52,000
Q3 2018 Nov 20, 2018	BUY	$22.5 - $39.35 $39,600 - $69,256	1,760 New	1,760 $54,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.